Lenaxolan (Doxazosin Mesilate)

Doxazosin mesilate selectively blocks alpha‑1 adrenergic receptors on vascular smooth muscle and prostatic tissue. This blockade prevents norepinephrine‑mediated contraction, causing blood vessels to dilate and reducing peripheral resistance, while also relaxing the prostate to ease urinary obstruction.

The specific dose of Lenaxolan is determined by the prescribing healthcare professional based on the patient’s medical condition, response to therapy, and other individual factors. Patients should follow the dosage instructions provided by their prescriber and not adjust the dose on their own.

Safety data for doxazosin mesilate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the Lenaxolan product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Lenaxolan (doxazosin) belongs to the alpha‑1 blocker class, which lowers blood pressure by vasodilation. Compared with ACE inhibitors, beta‑blockers, or calcium‑channel blockers, it may be chosen for patients who also have BPH symptoms, as it simultaneously improves urinary flow. Choice of therapy depends on individual patient profiles and comorbidities.

Store Lenaxolan at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture, heat, and direct sunlight. Do not store in a refrigerator or freezer unless otherwise directed by the manufacturer.

Lenaxolan is taken orally, usually once daily, with or without food, as directed by the prescriber. Swallow the tablet whole with a full glass of water and avoid crushing or chewing unless the formulation specifically allows it.

Serious adverse events may include severe hypotension, syncope, heart rhythm disturbances, priapism, and rare liver function abnormalities. Patients should seek immediate medical attention if they experience fainting, chest pain, prolonged erection, or signs of an allergic reaction such as swelling or difficulty breathing.

Lenaxolan is contraindicated in patients with known hypersensitivity to doxazosin or any component of the formulation. Caution is advised for individuals with severe liver disease, uncontrolled heart failure, or those taking medications that may cause dangerous blood‑pressure drops, such as phosphodiesterase‑5 inhibitors.